116 related articles for article (PubMed ID: 9299262)
1. Establishment and characterization of cell lines derived from uterine malignant mixed Müllerian tumor.
Yuan Y; Kim WH; Han HS; Lee JH; Park HS; Chung JK; Kang SB; Park JG
Gynecol Oncol; 1997 Sep; 66(3):464-74. PubMed ID: 9299262
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of human ovarian carcinoma cell lines.
Yuan Y; Kim WH; Han HS; Lee JH; Park HS; Chung JK; Kang SB; Park JG
Gynecol Oncol; 1997 Sep; 66(3):378-87. PubMed ID: 9299249
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of four human pancreatic carcinoma cell lines. Genetic alterations in the TGFBR2 gene but not in the MADH4 gene.
Ku JL; Yoon KA; Kim WH; Jang Y; Suh KS; Kim SW; Park YH; Park JG
Cell Tissue Res; 2002 May; 308(2):205-14. PubMed ID: 12037578
[TBL] [Abstract][Full Text] [Related]
4. Polysomy 8 in three cases of homologous malignant mixed Müllerian tumors of the uterus.
Gunawan B; Baumhoer D; Schulten HJ; Emons G; Füzesi L
Anticancer Res; 2003; 23(2B):1379-83. PubMed ID: 12820397
[TBL] [Abstract][Full Text] [Related]
5. Tissue polypeptide antigen production in a uterine carcinosarcoma cell line in a serum-free culture.
Emoto M; Iwasaki H; Kikuchi M; Shirakawa K
Gynecol Oncol; 1996 Mar; 60(3):443-9. PubMed ID: 8774655
[TBL] [Abstract][Full Text] [Related]
6. Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: a genetic study with special reference to histogenesis.
Jin Z; Ogata S; Tamura G; Katayama Y; Fukase M; Yajima M; Motoyama T
Int J Gynecol Pathol; 2003 Oct; 22(4):368-73. PubMed ID: 14501818
[TBL] [Abstract][Full Text] [Related]
7. The expression of epidermal growth factor receptor, HER-2/Neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma.
Swisher EM; Gown AM; Skelly M; Ek M; Tamimi HK; Cain JM; Greer BE; Muntz HG; Goff BA
Gynecol Oncol; 1996 Jan; 60(1):81-8. PubMed ID: 8557233
[TBL] [Abstract][Full Text] [Related]
8. Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus.
Clement PB; Zubovits JT; Young RH; Scully RE
Int J Gynecol Pathol; 1998 Jul; 17(3):211-22. PubMed ID: 9656116
[TBL] [Abstract][Full Text] [Related]
9. Ascitic fluid cytology of a malignant mixed Müllerian tumor of the peritoneum: a report of two cases with special reference to p53 status.
Kato N; Motoyama T
Diagn Cytopathol; 2009 Apr; 37(4):281-5. PubMed ID: 19217035
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
Mikami Y; Hata S; Kiyokawa T; Manabe T
Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the c-myc proto-oncogene occurs frequently in uterine sarcomas.
Jeffers MD; Richmond JA; Macaulay EM
Mod Pathol; 1995 Sep; 8(7):701-4. PubMed ID: 8539225
[TBL] [Abstract][Full Text] [Related]
12. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed müllerian tumours.
Abeln EC; Smit VT; Wessels JW; de Leeuw WJ; Cornelisse CJ; Fleuren GJ
J Pathol; 1997 Dec; 183(4):424-31. PubMed ID: 9496259
[TBL] [Abstract][Full Text] [Related]
14. Malignant mixed mullerian tumor in a rabbit (Oryctolagus cuniculus): case report with immunohistochemistry.
Goto M; Nomura Y; Une Y; Goldschmidt MH
Vet Pathol; 2006 Jul; 43(4):560-4. PubMed ID: 16847001
[TBL] [Abstract][Full Text] [Related]
15. Primary osteosarcoma of the uterus: report of a case with immunohistochemical analysis.
Emoto M; Iwasaki H; Kawarabayashi T; Egami D; Yoshitake H; Kikuchi M; Shirakawa K
Gynecol Oncol; 1994 Sep; 54(3):385-8. PubMed ID: 8088619
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotype of human ovarian malignancies (cystadenocarcinomata and mixed müllerian tumor) established in SCID mice.
Schumacher U; Adam E; Dietl J; Horny HP
Exp Mol Pathol; 1997 Apr; 64(2):103-13. PubMed ID: 9316588
[TBL] [Abstract][Full Text] [Related]
17. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.
Maxwell GL; Chandramouli GV; Dainty L; Litzi TJ; Berchuck A; Barrett JC; Risinger JI
Clin Cancer Res; 2005 Jun; 11(11):4056-66. PubMed ID: 15930340
[TBL] [Abstract][Full Text] [Related]
18. Primary peritoneal malignant mixed Müllerian tumors. A clinicopathologic, immunohistochemical, and genetic study.
Shen DH; Khoo US; Xue WC; Ngan HY; Wang JL; Liu VW; Chan YK; Cheung AN
Cancer; 2001 Mar; 91(5):1052-60. PubMed ID: 11251959
[TBL] [Abstract][Full Text] [Related]
19. SNU cell lines and their application for cancer research.
Park JG
Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():89-98. PubMed ID: 11890121
[TBL] [Abstract][Full Text] [Related]
20. Primary mesenteric malignant mixed mesodermal (müllerian) tumor with neuroendocrine differentiation.
Cokelaere K; Michielsen P; De Vos R; Sciot R
Mod Pathol; 2001 May; 14(5):515-20. PubMed ID: 11353063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]